Contact Information
About Ishita Jindal, MBBS
Ishita Jindal, MBBS, is a pediatric endocrinologist with particular interests in type 1 diabetes, type 2 diabetes and obesity. She completed her pediatric residency at John H Stroger Hospital of Cook County in 2017, and a fellowship in pediatric endocrinology at Texas Children’s Hospital, Baylor College of Medicine in 2020. She is the Director of Pediatric Diabetes Center at the Massachusetts General Hospital for Children (MGHfC).
Departments, Centers, & Programs:
Clinical Interests:
- Obesity
- Type 1 Diabetes
- Type 2 Diabetes
Treats:
- Pediatrics
Languages:
- Hindi
Locations
Mass General for Children: Pediatric Endocrine Program and Diabetes Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2909
Mass General for Children: Pediatric Specialties
54 Baker Ave Extension
Suite 302
Concord, MA 01742
Phone: 888-644-3248
Mass General Brigham Healthcare Center
102-104 Endicott St.
Danvers, MA 01923
Phone: 617-726-2909
Fax: 617-643-9140
Medical Education
- MBBS, Chandigarh Medical College (Govt Medical College)
- Fellowship, Texas Children's Hospital
American Board Certifications
- Pediatric Endocrinology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Reviews: Comments and Ratings
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.